BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center for Biomedical System Design - ECPv5.16.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Center for Biomedical System Design
X-ORIGINAL-URL:https://newdigs.tuftsmedicalcenter.org
X-WR-CALDESC:Events for Center for Biomedical System Design
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20161128T000000
DTEND;TZID=UTC:20161128T000000
DTSTAMP:20260426T140340
CREATED:20180928T145127Z
LAST-MODIFIED:20180928T145127Z
UID:584-1480291200-1480291200@newdigs.tuftsmedicalcenter.org
SUMMARY:Address by Gerald J. Dal Pan\, MD\, MHS
DESCRIPTION:The FDA’s Director of the Office of Surveillance and Epidemiology in FDA’s Center for Drug Evaluation and Research will deliver the address\, “Assessing the Impact of Postmarketing Regulatory Programs and Actions.” Please note that participation is by invitation only.
URL:https://newdigs.tuftsmedicalcenter.org/event/address-by-gerald-j-dal-pan-md-mhs/
CATEGORIES:Speaking Engagement
END:VEVENT
END:VCALENDAR